ROPER TECHNOLOGIES, INC.

ROP

CIK 0000882835 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$2.06B
↑+9.7% +$182Mvs FY2024 (Q4)
Operating Income
$588M
↑+12.1% +$64Mvs FY2024 (Q4)
Net Income
$428M
↑+31.7% +$103Mvs FY2024 (Q4)
Gross Profit
$1.43B
↑+11.5% +$148Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
31/100
  • Profitability
    7ROIC 6.4% (10% = solid, 20%+ = moat)
  • Liquidity
    1Current Ratio 0.52 (above 1.5 = solid)
  • Leverage
    77D/E 0.47 (under 0.5 = conservative)
  • Efficiency
    3Asset Turnover 0.24x (1.0+ = capital-efficient)
  • Growth
    49Revenue YoY +9.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    48Op Margin 28.6% · trend -0.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ROP's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 51.2%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$783.09
Total enterprise IV
$84.73B
Diluted shares
0.11B
Terminal PV
$65.79B (78% of total)
Year-5 FCF
$7.75B
YearProjected FCFDiscounted PV
+1$3.18B$2.89B
+2$3.97B$3.28B
+3$4.96B$3.73B
+4$6.20B$4.24B
+5$7.75B$4.81B
Terminal$105.95B$65.79B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Dividends paid (TTM)
$355M
cash returned to holders
Stock-based comp (TTM)
$166M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$34.58B
everything owned
Total liabilities
$14.70B
everything owed
Stockholders' equity
$19.88B
shareholder claim
Net debt
$9.00B
LT debt minus cash

Recent performance · 72 quarters

Revenue↑+9.7% +$182M
$2.06B
Net Income↓-7.3% -$34M
$428M
Free Cash Flow↑+2.2% +$16M
$738M
Operating Margin↑+0.6pts
28.6%

Drill down